Navigation Links
Neiker-Tecnalia makes progress in detection and prevention of infection by visna maedi virus
Date:1/19/2011

Researchers at Neiker-Tecnalia (the Basque Institute for Agricultural Research and Development) have undertaken a study on the epidemiology and diagnosis of infection by visna/maedi virus. This is a virus that affects sheep herds causing chronic interstitial pneumonia, mastitis and neurological disorders. The study confirmed that horizontal transmission (direct contact between infected animals) of the virus is the most likely path of infection, rather than vertical transmission (from infected suckling milk or colostrum). Since there is no current effective treatment against this virus, the study demonstrated the importance of control methods aimed at reducing direct contact between infected animals.

Visna/maedi virus (VMV) causes a slow and fatal disease in sheep. It is mainly associated with clinical symptoms of chronic interstitial pneumonia, but it is also linked to other clinical conditions such as arthritis, encephalitis and mastitis. The disease is widespread throughout the world and the infection has considerable historical importance. It gave rise to the discovery of slow viral infections and pointed to the difficulty in controlling them in international trade. Moreover, while it does not affect humans, it was first described within the group in which AIDS was subsequently included.

The studies carried out by Dr. Iratxe Leginagoikoa, PhD, have shown that VMV horizontal transmission is more important than vertical transmission. Thereby the need to detect infected animals rapidly, rearing the flocks in good conditions of space and ventilation and, reduce contact with infected animals in order to avoid its propagation within the flock.

Intensive stabling increases infection

During the first part of the study transmission of VMV through direct contact was monitored amongst 190 one-year-old lambs of the Latxa breed. Animals were divided into two groups: one subjected to horizontal infection at high pressure and the
'/>"/>

Contact: Amaia Portugal
a.portugal@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Neiker-Tecnalia underlines the need to maintain programs for monitoring pathogens in wildlife
2. Neiker-Tecnalia study use of oilseedrape and sunflower oils to produce fuel and feed for herds
3. Neiker-Tecnalia confirms need to undertake epidemiological monitoring programs for ticks
4. Trustee makes donation to start new solar energy research center at Rensselaer
5. What makes an axon an axon?
6. Feed a cold, feed a fever: Research shows calorie cut makes it harder to fight flu
7. Fly guy makes memory breakthrough
8. Our unconscious brain makes the best decisions possible
9. Biophysical Reviews makes debut in 2009
10. Tree lizard’s quick release escape system makes jumpers turn somersaults
11. Rett Syndrome Research Trust advisor makes significant discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... the pancreas digesting itself resulting in severe abdominal pain, ... around 20,000 patients are diagnosed with the disease resulting ... treatment is restricted to intravenous fluid and nutritional support. ... Life Sciences, who led the research, said "The major ... stones and excessive alcohol intake combined with a high ...
(Date:8/20/2014)... , Aug. 20, 2014 /CNW/ -  Issue ... and can quickly become life threatening for some children.    ... as 1.2 million Canadians have food allergies and this number ... cent of children are estimated to have food allergies.  ... mild skin irritations and hives to breathing difficulties and loss ...
(Date:8/20/2014)... of Health has awarded the Oklahoma Medical Research Foundation ... on anthrax and the bacteria,s effects on humans. ... and his colleagues have studied the human immune response ... for Human Immunology. The original funding came soon after ... heels of the terrorist attacks of Sept. 11, 2001. ...
Breaking Biology News(10 mins):Insulin offers new hope for the treatment of acute pancreatitis 2Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3$14.5 million grant awarded to continue anthrax studies 2
... United States, African Americans have approximately twice the risk ... a similar prevalence in earlier stages of chronic kidney ... (GW) researcher Dominic Raj, M.D., identifies factors that mediate ... black patients and white patients, as well as among ...
... range-wide assessment of the bonobo (formerly known as the ... known and endangered great ape is quickly losing space ... of usable habitat is attributed to both forest fragmentation ... of Georgia, University of Maryland, the Wildlife Conservation Society, ...
... University School of Medicine (BUSM) and Boston Medical Center ... initiative funded by the Bill & Melinda Gates Foundation. ... BMC, and Ducksoo Kim, MD, professor of radiology at ... fellowship at BMC, will use nanotechnology to develop a ...
Cached Biology News:Genetics contribute to increased risk for end-stage renal disease for African Americans with CKD 2Study finds the forgotten ape threatened by human activity and forest loss 2Study finds the forgotten ape threatened by human activity and forest loss 3BUSM/BMC receives Grand Challenges Explorations grant to develop next generation condom 2BUSM/BMC receives Grand Challenges Explorations grant to develop next generation condom 3
(Date:8/21/2014)... -- China Cord Blood Corporation (NYSE: CO ) ... results for the first quarter of fiscal year 2015 ... the US.  The Company will host ... August 29, 2014 to discuss its financial performance and ... followed by a question and answer session.  Interested parties ...
(Date:8/21/2014)... Gallus BioPharmaceuticals , LLC, ... manufacturing organization (CMO) announced today that it has ... company focused on the development of innovative approaches ... anti-prostate specific membrane antigen (PSMA) monoclonal antibody used ... the agreement the antibody will be produced in ...
(Date:8/20/2014)... of patented university inventions licensed to biotechnology firms ... commercialization. To open these roadblocks, the researchers suggest ... the discovery stage could lead to faster commercialization ... derived from discoveries made in university laboratories and ... during clinical trials, which have a high failure ...
(Date:8/20/2014)... 2014 High performance computing (HPC) ... most complete climate and Earth system model to ... issues. , Eight national laboratories, including Lawrence ... Center for Atmospheric Research, four academic institutions and ... participating national laboratories include Argonne, Brookhaven, Lawrence Berkeley, ...
Breaking Biology Technology:China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3
... is pleased to announce the,never- before assembly of ... Lighting the Onco-Pipeline -- Innovations in Stem Cell,Biomarker, ... in Tampa,Florida. iiBIG is particularly pleased to join ... Florida, University of Florida, Shands,Cancer Center, Scripps Florida, ...
... Ultra-Fine Beam Shaping Device Optimized for Targeting ... Stereotactic Radiotherapy and Radiosurgery, PALO ALTO, ... (NYSE: VAR ) has received FDA ... (MLC), an ultra-fine beam shaping,device for radiosurgery. ...
... Morria Biopharmaceuticals Plc, a,private biopharmaceutical company ... today that it has,appointed Rosemary Mazanet M.D., ... Mazanet has significant experience in both executive ... Dr. Mazanet serves on the Board of ...
Cached Biology Technology:Lighting the Onco-Pipeline, Stem Cell Cancer, and More at Global Cancer Congress, January 28-29, 2008, Tampa 2Lighting the Onco-Pipeline, Stem Cell Cancer, and More at Global Cancer Congress, January 28-29, 2008, Tampa 3Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery 2Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery 3Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer 2
... Custom monoclonal antibody development to targets including ... molecules, DNA, and cancer-specific surface antigens. ... and is completed in approximately 40 days ... nature of antigens). Phase I: Immunization, ...
... Clone/PAD: ZMD.460. Immunogen: Synthetic peptide ... human C35 protein (chromosome 17 open reading ... Specific for the C35 protein. On ... at ~15 kDa band. Reactivity: Human ...
... Peptide sequences: Two separate ... corresponding to the same sequence used ... antiserum (Catalog No. 160890) ... with Cayman's guanylate cyclase polyclonal antiserum ...
Immunogen: Secretory component isolated from human colostrum. Storage: 4 C...
Biology Products: